Analysts on Wall Street project that CF Industries (CF) will announce quarterly earnings of $1.47 per share in its forthcoming report, representing a decline of 48.4% year over year. Revenues are projected to reach $1.47 billion, declining 26.8% from the same quarter last year. Over the last 30 days, there has been an upward revision of 10.4% in the consensus EPS estimate for the quarter, leading to its current level. This signifies the covering analysts' collective reconsideration of their initial forecasts over the course of this timeframe. Before a company announces its earnings, it is essential to take into account any changes made to earnings estimates. This is a valuable factor in predicting the potential reactions of investors toward the stock. Empirical research has consistently shown a strong correlation between trends in earnings estimate revisions and the short-term price performance of a stock. While it's common for investors to rely on consensus earnings and revenue estimates for assessing how the business may have performed during the quarter, exploring analysts' forecasts for key metrics can yield valuable insights. With that in mind, let's delve into the average projections of some CF metrics that are commonly tracked and projected by analysts on Wall Street. The combined assessment of analysts suggests that 'Net Sales- Ammonia' will likely reach $312.27 million. The estimate suggests a change of -26.4% year over year. The collective assessment of analysts points to an estimated 'Net Sales- Granular Urea' of $445.82 million. The estimate suggests a change of -27% year over year. It is projected by analysts that the 'Net Sales- UAN (urea ammonium nitrate)' will reach $447.35 million. The estimate points to a change of -32.9% from the year-ago quarter. The consensus estimate for 'Net Sales- AN (ammonium nitrate)' stands at $112.06 million. The estimate suggests a change of -29.5% year over year. Based on the collective assessment of analysts, 'Average selling price per product ton - UAN (urea ammonium nitrate)' should arrive at $276.90. The estimate compares to the year-ago value of $401. The consensus among analysts is that 'Sales volume by product - UAN (urea ammonium nitrate)' will reach 1,680.45 KTon. The estimate is in contrast to the year-ago figure of 1,662 KTon. Analysts forecast 'Sales volume by product - Granular Urea' to reach 1,228.72 KTon. The estimate compares to the year-ago value of 1,323 KTon. According to the collective judgment of analysts, 'Sales volume by product - Ammonia' should come in at 680.21 KTon. Compared to the present estimate, the company reported 652 KTon in the same quarter last year. The average prediction of analysts places 'Average selling price per product ton - Ammonia' at $455.39. The estimate compares to the year-ago value of $650. Analysts' assessment points toward 'Average selling price per product ton - Granular Urea' reaching $352.42. The estimate compares to the year-ago value of $462. Analysts expect 'Tons of product sold - Total' to come in at 4,573.65 KTon. Compared to the current estimate, the company reported 4,535 KTon in the same quarter of the previous year. Analysts predict that the 'Average selling price per product ton - AN (ammonium nitrate)' will reach $309.53. The estimate compares to the year-ago value of $425. View all Key Company Metrics for CF here>>> Shares of CF have experienced a change of -3% in the past month compared to the -2.5% move of the Zacks S&P 500 composite. With a Zacks Rank #3 (Hold), CF is expected to mirror the overall market performance in the near future. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>> Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report CF Industries Holdings, Inc. (CF):Free Stock Analysis Report To read this article on Zacks.com click here. Zacks Investment Research
CF (CF) Q1 Earnings on the Horizon: Analysts' Insights on Key Performance Measures
You are reading a free article with opinions that may differ from the recommendation given by Kalkine in its paid research reports. Become a Kalkine member today to get access to our research reports, in-depth technical and fundamental research. Learn more
Start Your Free Trial Now!Download Free Report – Explore 3 Stock Ideas & Industry Insights
Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.
All investments involve risk—consider independent advice before making any investment decisions.
View 3 Research ReportsThis information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.
Please wait processing your request...